Topic · Clinical Biochemistry
Advanced Glycation End Products research
Advanced Glycation End Products research is a research topic within Clinical Biochemistry. Science Explorer counts 23k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the biochemistry and molecular cell biology of diabetic complications, particularly exploring the role of Advanced Glycation End Products (AGEs), HMGB1, oxidative stress, inflammation, and the receptor for AGEs (RAGE) in the pathobiology of diabetes. The papers also delve into the involvement of mitochondrial superoxide, toll-like receptors, necrotic cells, and cellular signaling pathways in diabetic complications.
- Advanced Glycation End Products
- HMGB1
- Oxidative Stress
- Inflammation
- RAGE
- Diabetes
- Mitochondrial Superoxide
- Toll-like Receptors
- Necrotic Cells
- Cellular Signaling
- Research works
- 23k fractional, since 1950
- In the world top 10%
- 2.3k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +0% the tick is no change
- Largest producer
China
48% of the 10 largest, 2022-now
Drawing this view